Gavin Gassen, M.D. Brings His Expertise to ENT and Allergy Associates’ Poughkeepsie Office

36 minutes ago
GlobeNewswire

Dr. Gassen will see both adult and pediatric patients at ENTA’s office at 21 Reade Place, Suite 3200, Poughkeepsie, NY,…

Thailand Consumer Confidence Hits Over 2-Year Low

3 hours ago

The consumer confidence index from the University of the Thai Chamber of Commerce fell to 54.2 in May 2025, a…

Steel Prices Fall on Risk-Off Sentiment

3 hours ago

Steel rebar futures declined to approximately CNY 2,960 per tonne on Thursday, retreating from a two-week peak against the backdrop…

Offshore Yuan Ends 2-Session Decline

3 hours ago

On Thursday, the offshore yuan strengthened to approximately 7.18 per dollar, ending a brief two-day decline, as it was buoyed…

Romania Inflation Rate at Over 1-Year High

3 hours ago

Romania experienced an increase in its annual inflation rate, reaching 5.45% in May 2025, up from 4.85% in April, which…

UK Manufacturing Output Falls 0.9% in April, Worse than Forecast

3 hours ago

In April 2025, manufacturing production in the UK experienced a decline of 0.9% compared to the previous month. This drop…

Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma

3 hours ago

Proceeds to fund Phase 1/2 trial of EO2463 OncoMimics™, as a monotherapy or in combination, to treat multiple forms of…

Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils home care services network

3 hours ago

Press release June 12th, 2025           Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils…

CREDIT AGRICOLE SA: Crédit Agricole Santé & Territoires announces the signing of an agreement to acquire Petits-fils, the leading provider of at-home services for seniors in France, from Clariane

4 hours ago

Press Release Montrouge, 12 June 2025 Crédit Agricole Santé & Territoires announces the signing of an agreement to acquire Petits-fils,…

Significant efficacy benefit of IMBRUVICA® (ibrutinib) plus venetoclax versus acalabrutinib plus venetoclax in frontline treatment of patients with chronic lymphocytic leukaemia suggested by indirect treatment comparison

4 hours ago

Cross-study findings indicate significant clinical benefit of frontline fixed-duration ibrutinib plus venetoclax with improved likelihood of undetectable minimal residual disease…

This website uses cookies.